JP2010525055A5 - - Google Patents

Download PDF

Info

Publication number
JP2010525055A5
JP2010525055A5 JP2010506110A JP2010506110A JP2010525055A5 JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5 JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5
Authority
JP
Japan
Prior art keywords
corm
medicament
manufacture
treatment
infectious diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010506110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010525055A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2008/000017 external-priority patent/WO2008130261A1/en
Publication of JP2010525055A publication Critical patent/JP2010525055A/ja
Publication of JP2010525055A5 publication Critical patent/JP2010525055A5/ja
Pending legal-status Critical Current

Links

JP2010506110A 2007-04-24 2008-04-24 一酸化炭素による感染症の処置 Pending JP2010525055A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92597607P 2007-04-24 2007-04-24
PCT/PT2008/000017 WO2008130261A1 (en) 2007-04-24 2008-04-24 Treatment of infections by carbon monoxide

Publications (2)

Publication Number Publication Date
JP2010525055A JP2010525055A (ja) 2010-07-22
JP2010525055A5 true JP2010525055A5 (enExample) 2012-06-28

Family

ID=39720470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506110A Pending JP2010525055A (ja) 2007-04-24 2008-04-24 一酸化炭素による感染症の処置

Country Status (4)

Country Link
US (1) US20100196516A1 (enExample)
EP (1) EP2148688A1 (enExample)
JP (1) JP2010525055A (enExample)
WO (1) WO2008130261A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
CA2534415A1 (en) * 2003-08-04 2005-02-17 Northwick Park Institute For Medical Research Therapeutic delivery of carbon monoxide
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2009013612A1 (en) * 2007-07-24 2009-01-29 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos, Lda. Prevention of gastric ulcery by carbon monoxide
JP5978291B2 (ja) * 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化炭素放出分子およびその使用
JP6134710B2 (ja) * 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
DE102014008685A1 (de) * 2014-06-13 2015-12-17 Lorenz Meinel Freisetzungssystem für therapeutisches Gas
WO2016187545A1 (en) * 2015-05-21 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing venom related poisoning
US10512652B2 (en) 2015-07-20 2019-12-24 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
EP3524290A1 (en) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids
EP3808351A1 (en) 2019-10-14 2021-04-21 Julius-Maximilians-Universität Würzburg Membrane-based two component therapeutic gas release system for oral administration
EP3878471A1 (en) 2020-03-13 2021-09-15 Julius-Maximilians-Universitaet Wuerzburg Therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide
EP4275682A1 (en) * 2022-05-12 2023-11-15 Institut National De La Sante Et De La Recherche Medicale - Inserm Carbon monoxide-releasing molecule (corm) or composition thereof for use in the treatment or the prevention of an intestinal dysbiosis in a subject
JP2025529389A (ja) 2022-09-09 2025-09-04 ユリウスーマキシミリアンーウニベルジテート ブルツブルク，イン フェルトレトゥン デス フライシュタート バイエルン 機能的配偶子の保存方法
CN119157883B (zh) * 2024-11-15 2025-02-14 温州医科大学附属口腔医院 一种抗菌剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065250A (en) * 1960-05-13 1962-11-20 Hercules Powder Co Ltd Nitrile-metal carbonyl complexes
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
CA2442457A1 (en) * 2001-03-30 2002-10-10 Roland Buelow Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
MXPA04012863A (es) * 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
EP1537163B1 (en) * 2002-09-09 2008-10-29 Nektar Therapeutics Al, Corporation Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
CA2534415A1 (en) * 2003-08-04 2005-02-17 Northwick Park Institute For Medical Research Therapeutic delivery of carbon monoxide
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
WO2007073225A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda. Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) * 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
AU2007328549A1 (en) * 2006-12-06 2008-06-12 Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

Similar Documents

Publication Publication Date Title
JP2010525055A5 (enExample)
JP2014530840A5 (enExample)
HUE043175T2 (hu) Szintetikus triterpenoidok és alkalmazásuk betegség kezelésében
JP2009256391A5 (enExample)
IL246697A0 (en) Multiple exon skipping compositions for use in treating muscular dystrophy
JP2010507682A5 (enExample)
SMT201300007B (it) Trattamento di una malattia respiratoria
JP2013014622A5 (enExample)
JP2009039101A5 (enExample)
JP2011526809A5 (enExample)
JP2012504217A5 (enExample)
JP2015525757A5 (enExample)
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
PT2236149E (pt) Composição medicinal para o tratamento de doenças infeciosas respiratórias
JP2009215191A5 (enExample)
JP2007520565A5 (enExample)
JP2012516348A5 (enExample)
JP2006305390A5 (enExample)
JP2009532412A5 (enExample)
JP2008519810A5 (enExample)
JP2009001575A5 (enExample)
JP2011529851A5 (enExample)
JP2011503050A5 (enExample)
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
SI1714647T1 (sl) Uporaba agomelatina pri izdelavi zdravila za zdravljenje bipolarnih motenj